After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Bristol-Myers Squibb Co is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – General industry. The current market capitalization of Bristol-Myers Squibb Co is $121.49B. A total of 11.21 million shares were traded on the day, compared to an average of 11.06M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, BMY has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, BOERNER CHRISTOPHER S. bought 2,000 shares of BMY for 55.05 per share on Feb 20 ’25. After the transaction, the Chief Executive Officer now owns 104,626 company shares. In a previous transaction on Feb 14 ’25, Hirawat Samit bought 1,823 shares at 54.84 per share. BMY shares that EVP,Chief Med.Offr.,Drug Dev. owns now total 63,932.
Among the insiders who sold shares, Holzer Phil M disposed of 700 shares on Nov 04 ’24 at a per-share price of $55.62. This resulted in the SVP and Controller holding 11,760 shares of BMY after the transaction. In another insider transaction, Hirawat Samit bought 1,830 shares at $54.67 per share on Nov 01 ’24. Company shares held by the EVP,Chief Med.Offr.,Drug Dev. now total 62,109.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. BMY’s most recent ex-dividend date was 4.14% when it declared a $0.62 quarterly dividend that was paid in cash on 4/4/2025. Previously, the company paid the dividend on 1/3/2025 with an ex-dividend date of 4.38%. The BMY stock dividend was $0.62 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for BMY in the last 3 months, the mean price target is $60.68 with high estimates of $70.00 and low estimates of $37.00. In terms of 52-week highs and lows, BMY has a high of $61.10 and a low of $39.35.
As of this writing, BMY has an earnings estimate of $1.53 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of $1.62 per share and a lower estimate of $1.35.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BMY’s latest balance sheet shows that the firm has $17.22B in Cash & Short Term Investments as of fiscal 2021. There were $45.60B in debt and $21.87B in liabilities at the time. Its Book Value Per Share was $8.05, while its Total Shareholder’s Equity was $36.01B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMY is Buy with a score of 3.48.
